Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary adenosine before PCI in non-ST elevation acute coronary syndrome
ACTRN12609000342213Phase 3Recruiting
- Sponsor
- Monash Medical Centre
- Start
- Oct 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of adenosine in non–ST-segment elevation acute coronary syndrome (NSTE-ACS) (2 arms), sponsored by Monash Medical Centre. Primary endpoint: Periprocedural myocardial injury. Started Oct 2008; status: recruiting.
02
Drugs
adenosine
03
Conditions
non–ST-segment elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on ACTRN12609000342213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000342213.